Cargando…
DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma
BACKGROUND: Multiple myeloma (MM) is a heterogeneous plasma cell malignancy that remains challenging to cure. Global hypomethylation correlates with an aggressive phenotype of the disease, while hypermethylation is observed at particular regions of myeloma such as B cell-specific enhancers. The rece...
Autores principales: | Alberge, Jean-Baptiste, Magrangeas, Florence, Wagner, Mirko, Denié, Soline, Guérin-Charbonnel, Catherine, Campion, Loïc, Attal, Michel, Avet-Loiseau, Hervé, Carell, Thomas, Moreau, Philippe, Minvielle, Stéphane, Sérandour, Aurélien A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607866/ https://www.ncbi.nlm.nih.gov/pubmed/33138842 http://dx.doi.org/10.1186/s13148-020-00953-y |
Ejemplares similares
-
Logic programming reveals alteration of key transcription factors in multiple myeloma
por: Miannay, Bertrand, et al.
Publicado: (2017) -
Exploring the impact of dexamethasone on gene regulation in myeloma cells
por: Bessonneau-Gaborit, Victor, et al.
Publicado: (2023) -
The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability
por: Derrien, Jennifer, et al.
Publicado: (2021) -
Deciphering the chronology of copy number alterations in Multiple Myeloma
por: Aktas Samur, Anil, et al.
Publicado: (2019) -
The shaping and functional consequences of the dosage effect landscape in multiple myeloma
por: Samur, Mehmet K, et al.
Publicado: (2013)